Amryt Pharma plc Operating Expenses 2011-2026 | AMYT

Annual Operating Expenses Amryt Pharma plc

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	109 M	52.2 M	27.9 M	25.9 M	6.95 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
109 M	6.95 M	44.4 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	216 M	$ 19.67	0.51 %	$ 919 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
BioNTech SE BNTX	512 M	$ 88.99	0.25 %	$ 27.2 B	Germany
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Cabaletta Bio CABA	172 M	$ 2.85	2.52 %	$ 286 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Compugen Ltd. CGEN	40.4 M	$ 2.1	1.94 %	$ 196 M	Israel
Corbus Pharmaceuticals Holdings CRBP	85.3 M	$ 8.4	1.08 %	$ 112 M	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Enlivex Therapeutics Ltd. ENLV	19.3 M	$ 1.09	-9.17 %	$ 22.4 M	Israel
Equillium EQ	23.6 M	$ 2.06	-	$ 118 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Esperion Therapeutics ESPR	343 M	$ 2.78	0.54 %	$ 578 M	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.35	1.13 %	$ 344 M	Britain
Halozyme Therapeutics HALO	218 M	$ 63.86	0.98 %	$ 7.65 B	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Harmony Biosciences Holdings HRMY	462 M	$ 27.64	0.18 %	$ 1.59 B	USA
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	142 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Ironwood Pharmaceuticals IRWD	287 M	$ 3.23	1.25 %	$ 514 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Johnson & Johnson JNJ	37.3 B	$ 239.97	0.02 %	$ 578 B	USA
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
Karyopharm Therapeutics KPTI	265 M	$ 5.3	1.73 %	$ 646 K	USA
Kazia Therapeutics Limited KZIA	8.82 M	$ 7.3	-	$ 967 M	Australia